Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06501105

Performance of WOUNDCHEK Bacterial Status

The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) when the test result is used to inform treatment decisions.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Northwell Health Comprehensive Wound Healing & Hyperbaric Center

Lake Success, New York, 11042, United States

Location status: Recruiting

Location contact

Alisha Oropallo, MD

CONTACT

[email protected]

516-233-3780

About this study

The clinician treating the wound will be allowed to use the test result in treatment decisions. The pretest treatment plan will be documented on the Case Report Form (CRF) prior to performing the WCBS test. After receiving the test result the clinician will document the post-test treatment plan. The healing outcome at 12 weeks following the test will be recorded on the CRF. The study will evaluate the healing outcomes compared to when test results are not used to assist in treatment decisions with study success defined as a higher healing rate and/or mean wound size reduction for WCBS positive wounds than obtained in the study PROT-2023-001. Also, the healing rate of wounds with a negative test result will be compared to the pretest rate to ensure that clinicians do not neglect and under treat this cohort with success criteria being that the WCBS negative wound healing rate is not worse than the pre-test healing rate. Additionally, the study will establish whether there are any device related Serious Adverse Events (SAEs) or Unanticipated Adverse Device Effects (UADEs).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has presented to the participating study site with a VLU, DFU and / or a PU that is suspected not to be infected, as determined by the Investigator and/ or study staff - defined as one that does not show more than two of the NERDS signs of infection.
  • Subject is 18 years of age or older.
  • The wound is between 21 days and 6 months of age or more than 6 months of age if less than 1cm2 in area.
  • Subject agrees to complete all aspects of the study and provides written Informed Consent per IRB requirements.

Exclusion criteria

  • Subject does not meet inclusion criteria.
  • Target wound contains a malignancy.
  • Subject has hypersensitivity of the wound or painful wound surface which prevents touching/swabbing of the wound surface.
  • Subject is confirmed to be positive for HIV or hepatitis

.

  • Subject is unable or unwilling to provide informed consent.
  • A designated wound area may only be enrolled once in the study. For example, if an enrolled wound heals to complete closure and then re-opens, it cannot be re-enrolled in this study.

Treatment and study plan

WOUNDCHEK Bacterial Status

Device

Lateral flow point of care test for the qualitative detection of bacterial protease activity in wound fluid.

Primary outcomes

  1. Healing rate and mean percent wound area reduction

    Time frame: 12 weeks

    Rate of healing and/or mean percent wound area reduction for WOUNDCHEK Bacterial Status positive wounds will be higher than obtained in the clinical study PROT-2023-001

Secondary outcomes

  1. WOUNDCHEK Bacterial Status negative wound healing rate

    Time frame: 12 weeks

    The pre-test non-healing rate (i.e., [Non-Healed wounds/Total wounds]*100) minus the WCBS Negative wound non-healing rate (i.e. [Non-healed wounds with a negative WCBS result/Total wounds]*100) will be less than or equal to zero.

  2. Adverse events

    Time frame: 12 weeks

    There will be no device related serious adverse events (SAE) or unanticipated adverse device effects (UADE).

Study contacts

Contact information is provided by the study sponsor or research team.

Jack Wilkens, MBA

CONTACT

[email protected]

305 926 8380

Simon W Bayliff, BS

CONTACT

[email protected]

+44 7917 650027

Sponsors and collaborators

Lead sponsor

Woundchek Laboratories BV

Industry

Collaborators

  • Northwell Health

Registry information

Official study title

Clinical Study to Evaluate the Performance of WOUNDCHEK Bacterial Status

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 15, 2024
Registry last updated
Jul 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.